Trials / Unknown
UnknownNCT04118634
A Registry Study on Biomarkers of Pulmonary Embolism
Evaluation of Performances of Biomarkers in Pulmonary Embolism
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 480 (estimated)
- Sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the value of biomarkers in the diagnosis and risk stratification of patients with suspected pulmonary embolism.
Detailed description
Management of patients with acute pulmonary embolism is a serious problem. The rapid and accurate diagnosis and risk stratification of these patients is an important unmet clinical need. The aim of the study is to evaluate the value of biomarkers, alone or in combination, in the diagnosis and risk stratification of patients with suspected pulmonary embolism presenting to the emergency department.
Conditions
Timeline
- Start date
- 2015-04-18
- Primary completion
- 2021-08-01
- Completion
- 2021-08-01
- First posted
- 2019-10-08
- Last updated
- 2020-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04118634. Inclusion in this directory is not an endorsement.